News

Technology News

Integral Molecular Launches MPS Platform

Tuesday, April 23, 2013 5:17:00 AM PDT | VentureDeal
   Philadelphia, Pennsylvania  --  Biotechnology company Integral Molecular has announced the launch of a new antibody discovery platform.

Called Membrane Protein Solutions (MPS), the platform enables users to isolate, characterize and engineer monoclonal antibodies against membrane protein targets.

The platform is designed to facilitate high concentration antigen presentation, epitope mapping and antibody engineering for the isolation and advancement of pre-clinical ready monoclonal antibodies that target GPCRs, ion channels or transporters.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1